Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME I)
Status:
Completed
Trial end date:
2007-05-09
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the absorption, systemic pharmacokinetics and
accumulation in the nail of AN2690 during a 28 day period of daily application of a 7.5%
solution of AN2690 to all 10 toenails of up to 25 otherwise healthy adult patients with
onychomycosis.